Physician

Sarah J Tarplin, M.D.

According to 2025 Medicare claims, Sarah Tarplin, M.D. (NPI: 1639559594) practices rheumatology in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is SOUTHEASTERN RHEUMATOLOGY ALLIANCE (NPI: 1114795663; TIN: 933460719) and primary practice location at 31404-6234. Tarplin is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Tarplin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 47,470 HCPCS/CPT codes, and received $606,735 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,823 prescription claims across 294 beneficiaries totaling $2,004,113 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 86 records totaling $2,018. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $7,739 to $2,004,113. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$303K$607K2021 Medicare payment: $85,150 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $285,540 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $459,974 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $606,735 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021674,499$85,150
202217219,855$285,540
202320532,585$459,974
202426347,470$606,735

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.0M$2.0M2015 Drug cost: $7,739 (USD; Tot_Drug_Cst)2016 Drug cost: $8,502 (USD; Tot_Drug_Cst)2017 Drug cost: $19,472 (USD; Tot_Drug_Cst)2018 Drug cost: $5,314 (USD; Tot_Drug_Cst)2019 Drug cost: $26,191 (USD; Tot_Drug_Cst)2020 Drug cost: $89,502 (USD; Tot_Drug_Cst)2021 Drug cost: $211,229 (USD; Tot_Drug_Cst)2022 Drug cost: $377,321 (USD; Tot_Drug_Cst)2023 Drug cost: $835,731 (USD; Tot_Drug_Cst)2024 Drug cost: $2,004,113 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201578143$7,739
20162955$8,502
20172093$19,472
201832141$5,314
201941235$26,191
202050185$89,502
2021115356$211,229
2022166732$377,321
20232451,234$835,731
20242941,823$2,004,113

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more150264$87
80053Blood test, comprehensive group of blood chemicals129165$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count133171$8
86140Measurement c-reactive protein for detection of infection or inflammation91115$5
85652Red blood cell sedimentation rate, to detect inflammation, automated91115$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept942,632$707,548
Humira(Cf) PenAdalimumab561,570$572,845
OtezlaApremilast311,046$169,426
Orencia ClickjectAbatacept28786$155,196
Actemra ActpenTocilizumab21588$69,409

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.86$2,018ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sarah J. Tarplin, M.D.?

Tedicare shows public-source Medicare data for Sarah J. Tarplin, M.D. (NPI 1639559594), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah J. Tarplin, M.D. have ACO affiliation data?

Sarah J. Tarplin, M.D. is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Sarah J. Tarplin, M.D.?

Sarah J. Tarplin, M.D. is linked to SOUTHEASTERN RHEUMATOLOGY ALLIANCE (billing NPI 1114795663) in the available physician profile data.

Does Sarah J. Tarplin, M.D. have Open Payments data?

Sarah J. Tarplin, M.D. has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.